These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2280827

  • 1. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls.
    Azorin JM, Raucoules D, Valli M, Levy C, Lancon C, Luccioni JM, Tissot R.
    Neuropsychobiology; 1990; 23(1):18-24. PubMed ID: 2280827
    [Abstract] [Full Text] [Related]

  • 2. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
    Wolkowitz OM, Doran AR, Breier A, Roy A, Jimerson DC, Sutton ME, Golden RN, Paul SM, Pickar D.
    Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
    [Abstract] [Full Text] [Related]

  • 3. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A, Jimerson DC, Pickar D.
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [Abstract] [Full Text] [Related]

  • 4. Noradrenergic function and the dexamethasone suppression test in depression.
    Morinobu S, Satoh H, Endoh M, Totsuka S.
    Jpn J Psychiatry Neurol; 1987 Dec; 41(4):669-76. PubMed ID: 3453415
    [Abstract] [Full Text] [Related]

  • 5. Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?
    Halbreich U, Sharpless N, Asnis GM, Endicott J, Goldstein S, Vital-Herne J, Eisenberg J, Zander K, Kang BJ, Shindledecker R.
    Arch Gen Psychiatry; 1987 Sep; 44(9):804-12. PubMed ID: 3632254
    [Abstract] [Full Text] [Related]

  • 6. The heterogeneity of 3-methoxy-4-hydroxyphenylglycol levels among depressed patients.
    Karege F, Bovier P, Gaillard JM, Tissot R.
    Acta Psychiatr Scand; 1989 Nov; 80(5):499-504. PubMed ID: 2596350
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma MHPG in dexamethasone-resistant depressed patients.
    Jimerson DC, Insel TR, Reus VI, Kopin IJ.
    Arch Gen Psychiatry; 1983 Feb; 40(2):173-6. PubMed ID: 6824413
    [Abstract] [Full Text] [Related]

  • 8. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
    Trestman RL, Lawrence TL, Coccaro EF, Harvey P, Bernstein D, Lawrence EK, Condello V, Mahon T, Yang RK, Knott P.
    Psychiatry Res; 1992 Sep; 43(3):199-213. PubMed ID: 1332095
    [Abstract] [Full Text] [Related]

  • 9. Plasma 3-methoxy-4-hydroxyphenylglycol in manic patients: relationships with clinical variables.
    Azorin JM, Pupeschi G, Valli M, Joanny P, Raucoules D, Lancon C, Tissot R.
    Acta Psychiatr Scand; 1990 Jan; 81(1):14-8. PubMed ID: 2330823
    [Abstract] [Full Text] [Related]

  • 10. Apparent phase advance in diurnal MHPG rhythm in depression.
    Gwirtsman HE, Halaris AE, Wolf AW, DeMet E, Piletz JE, Marler M.
    Am J Psychiatry; 1989 Nov; 146(11):1427-33. PubMed ID: 2817113
    [Abstract] [Full Text] [Related]

  • 11. Disruption of circadian MHPG rhythmicity in major depression.
    Piletz JE, DeMet E, Gwirtsman HE, Halaris A.
    Biol Psychiatry; 1994 Jun 01; 35(11):830-42. PubMed ID: 8054405
    [Abstract] [Full Text] [Related]

  • 12. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F, Haack D, Gerken A, Vecsei P.
    Biol Psychiatry; 1984 Mar 01; 19(3):281-91. PubMed ID: 6722226
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders.
    Zhou DF, Shen YC, Shu LN, Lo HC.
    Biol Psychiatry; 1987 Jul 01; 22(7):883-91. PubMed ID: 3607115
    [Abstract] [Full Text] [Related]

  • 14. Urinary MHPG in subgroups of depressed patients and normal controls.
    Beckmann H, Goodwin FK.
    Neuropsychobiology; 1980 Jul 01; 6(2):91-100. PubMed ID: 7354911
    [Abstract] [Full Text] [Related]

  • 15. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D, Levy C, Azorin JM, Bruno M, Valli M.
    Encephale; 1992 Jul 01; 18(6):611-6. PubMed ID: 1285270
    [Abstract] [Full Text] [Related]

  • 16. Diurnal neuroendocrine and autonomic function in acute and remitted depressed male patients.
    Trestman RL, Yehuda R, Coccaro E, Horvath T, Knott P, Gabriel S, Siever LJ.
    Biol Psychiatry; 1995 Apr 01; 37(7):448-56. PubMed ID: 7786958
    [Abstract] [Full Text] [Related]

  • 17. Depression and dexamethasone suppression testing in children and adolescents.
    Emslie GJ, Weinberg WA, Rush AJ, Weissenburger J, Parkin-Feigenbaum L.
    J Child Neurol; 1987 Jan 01; 2(1):31-7. PubMed ID: 3624827
    [Abstract] [Full Text] [Related]

  • 18. Effect of concurrent medical illness on dexamethasone suppression test results in depressed inpatients.
    Cooke RG, Warsh JJ, Stancer HC, Hasey GM, Jorna T, Langlet F.
    Can J Psychiatry; 1990 Feb 01; 35(1):31-5. PubMed ID: 2317731
    [Abstract] [Full Text] [Related]

  • 19. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
    Ko HC, Lu RB, Shiah IS, Hwang CC.
    Biol Psychiatry; 1997 Apr 01; 41(7):774-81. PubMed ID: 9084896
    [Abstract] [Full Text] [Related]

  • 20. Platelet 5-HT and plasma MHPG levels in patients with bipolar I and bipolar II depressions and normal controls.
    Shiah IS, Ko HC, Lee JF, Lu RB.
    J Affect Disord; 1999 Apr 01; 52(1-3):101-10. PubMed ID: 10357023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.